The global Bispecific Antibody Market is expected to reach US$ 500 million by the end of 2023, and US$ 1 billion by 2033, representing a 7.2% CAGR. The Bispecific Antibody business has benefited greatly from antibody engineering. Significant progress has been achieved in generating innovative antibody formats and engineering procedures that allow the creation of …